• Thu, September 29, 2016

by: WOPRAI

Market Maker Surveillance Report. MU, MBG, MPW, USO, WPX, DGAZ, Highest Net Buy Volume With Lowest Price Friction For Thursday

by: WOPRAI

Market Maker Surveillance Report. SPY, PFE, SXL, GE, SIRI, JD, Highest Net Sell Volume and Negative Price Friction For Thursda

by: WOPRAI

Market Maker Surveillance Report. MT, CHK, DNR, YHOO, GDX, JNK, Bearishly Biased Price Friction For Thursday, September 29th 2

by: WOPRAI

Xerium Technologies Inc. (NYSE:XRM), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In O

by: WOPRAI

Seattle Genetics, Inc. (NASDAQ:SGEN), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In

by: WOPRAI

GEL SqueezeTrigger Price is $37.02. There is $88,257,972 That Short Sellers Still Need To Cover.

by: WOPRAI

Skyline Corp (NYSE:SKY), Up By $2.94 (28.70%) After BUYINS.NET SqueezeTrigger Report Released on Monday, August 22nd 2016 at a

by: WOPRAI

Aduro Biotech Inc. (NASDAQ:ADRO), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our

by: WOPRAI

FibroGen Inc. (NASDAQ:FGEN), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Repor

by: WOPRAI

Alimera Sciences Inc. (NASDAQ:ALIM), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In O

by: WOPRAI

Spark Therapeutics Inc. (NASDAQ:ONCE), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In

by: WOPRAI

Pluristem Therapeutics Inc. (NASDAQ:PSTI), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outline

by: WOPRAI

bluebird bio Inc. (NASDAQ:BLUE), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our R

by: WOPRAI

United Therapeutics Corporation (NASDAQ:UTHR), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Out

by: WOPRAI

Xencor (NASDAQ:XNCR), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

Lion Biotechnologies Inc. (NASDAQ:LBIO), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined

by: WOPRAI

NHTC SqueezeTrigger Price is $29.57. There is $86,234,838 That Short Sellers Still Need To Cover.

by: WOPRAI

AXR SqueezeTrigger Price is $8.07. There is $238,065 That Short Sellers Still Need To Cover.

by: WOPRAI

Structured Products CORTS (NYSE:KCC), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In

by: WOPRAI

Anavex Life Sciences Corp (NASDAQ:AVXL), Up By $0.68 (20.52%) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, Sep

by: WOPRAI

Carrizo Oil & Gas Inc. (NASDAQ:CRZO), Up By $5.67 (16.76%) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, Septem

by: WOPRAI

Caterpillar Inc. (NYSE:CAT), Up By $6.23 (7.56%) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, September 27th 201

by: WOPRAI

CYTX SqueezeTrigger Price is $2.02. There is $915,670 That Short Sellers Still Need To Cover.

by: WOPRAI

IDT SqueezeTrigger Price is $17.08. There is $7,209,232 That Short Sellers Still Need To Cover.

by: WOPRAI

PLAY SqueezeTrigger Price is $38.48. There is $201,580,274 That Short Sellers Still Need To Cover.

by: WOPRAI

CSBR, DRYS, SPU, Removed From Naked Short Lists Today

by: WOPRAI

TQQQ, Has Remained On Naked Short Lists 13 Consecutive Days

by: WOPRAI

KWEB, BSPM, Added To Naked Short Lists Today

by: WOPRAI

BABY, CNBKA, HOTR, Expected to Trade Higher After Bullish Insider Trading

by: WOPRAI

KITE, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

VRA, PAY, DISH, OSUR, TLYS, AGIO, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

PFF, JNK, GOODO Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

TCRD, IL Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

SPSC, PGF, VSI, ROIC, VCIT, VCLT Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

AHGP Expected To Be Up Before Next Earnings Releases

by: WOPRAI

FBP Expected To Be Down Before Next Earnings Releases

by: WOPRAI

Biren Amin Maintained (VRTX) at Strong Buy with Decreased Target to $104 on, Sep 29th, 2016

by: WOPRAI

Jason McCarthy Maintained (BLUE) at Strong Buy with Increased Target to $100 on, Sep 29th, 2016

by: WOPRAI

Selman Akyol Downgraded (TRGP) to Hold on, Sep 29th, 2016

by: WOPRAI

Mark Moskowitz Maintained (STX) at Hold with Increased Target to $40 on, Sep 29th, 2016

by: WOPRAI

Chris Woronka Initiated (CCL) at Hold and Held Target at $48 on, Sep 29th, 2016

by: WOPRAI

Seth Rosenfeld Maintained (WOR) at Hold with Increased Target to $42 on, Sep 29th, 2016

by: WOPRAI

Elizabeth Suzuki Initiated (WOOF) at Strong Buy on, Sep 29th, 2016

by: WOPRAI

Edward Yruma Initiated (WMT) at Buy and Held Target at $30 on, Sep 29th, 2016

by: WOPRAI

Deepa Raghavan Initiated (TOL) at Buy on, Sep 29th, 2016

by: WOPRAI

Atul Maheswari Initiated (TPX) at Hold and Held Target at $15 on, Sep 29th, 2016

by: WOPRAI

Suji Desilva Initiated (AMBA) at Strong Buy and Held Target at $80 on, Sep 29th, 2016

by: WOPRAI

Mark Moskowitz Maintained (AAPL) at Buy and Held Target at $29 on, Sep 29th, 2016

Biren Amin Maintained (VRTX) at Strong Buy with Decreased Target to $104 on, Sep 29th, 2016

Biren Amin of Jefferies, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Decreased Target from $107 to $104 on, Sep 29th, 2016.

Biren has made no other calls on VRTX in the last 4 months.



There are 2 other peers that have a rating on VRTX. Out of the 2 peers that are also analyzing VRTX, 1 agrees with Biren's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Christopher Raymond of "Raymond James" Initiated at Hold on, Tuesday, September 13th, 2016


This is the rating of the analyst that currently disagrees with Biren

  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $139 on, Thursday, July 28th, 2016

Like: 👍